279 related articles for article (PubMed ID: 30326810)
1. [Therapy of Psoriasis Arthritis Taking into Account New Treatment Options].
Ryser C; Ciurea A
Praxis (Bern 1994); 2018; 107(21):1147-1153. PubMed ID: 30326810
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
3. Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations.
Gossec L; Coates LC; de Wit M; Kavanaugh A; Ramiro S; Mease PJ; Ritchlin CT; van der Heijde D; Smolen JS
Nat Rev Rheumatol; 2016 Dec; 12(12):743-750. PubMed ID: 27829672
[TBL] [Abstract][Full Text] [Related]
4. Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review.
Thibodaux RJ; Triche MW; Espinoza LR
Expert Opin Biol Ther; 2018 Jul; 18(7):821-827. PubMed ID: 29949399
[TBL] [Abstract][Full Text] [Related]
5. Ustekinumab : targeting the IL-17 pathway to improve outcomes in psoriatic arthritis.
Weitz JE; Ritchlin CT
Expert Opin Biol Ther; 2014 Apr; 14(4):515-26. PubMed ID: 24555741
[TBL] [Abstract][Full Text] [Related]
6. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Gottlieb A; Korman NJ; Gordon KB; Feldman SR; Lebwohl M; Koo JY; Van Voorhees AS; Elmets CA; Leonardi CL; Beutner KR; Bhushan R; Menter A
J Am Acad Dermatol; 2008 May; 58(5):851-64. PubMed ID: 18423261
[TBL] [Abstract][Full Text] [Related]
7. Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?
Orr C; Veale DJ
Ann Rheum Dis; 2014 Jun; 73(6):951-3. PubMed ID: 24790066
[No Abstract] [Full Text] [Related]
8. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
Armstrong AW; Gelfand JM; Boehncke WH; Armstrong EJ
J Rheumatol; 2013 Aug; 40(8):1434-7. PubMed ID: 23908540
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab for resistant psoriatic arthritis.
Wallis DE; Waldron NM; Korendowych E
J Rheumatol; 2013 Feb; 40(2):207. PubMed ID: 23378500
[No Abstract] [Full Text] [Related]
11. Inhibitors of phosphodiesterase 4 (PDE 4): A new therapeutic option in the treatment of psoriasis vulgaris and psoriatic arthritis.
Mazur M; Karczewski J; Lodyga M; Żaba R; Adamski Z
J Dermatolog Treat; 2015; 26(4):326-8. PubMed ID: 25424050
[TBL] [Abstract][Full Text] [Related]
12. New targets in psoriatic arthritis.
Braun J
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii30-ii37. PubMed ID: 27856658
[TBL] [Abstract][Full Text] [Related]
13. Biological and synthetic target DMARDs in psoriatic arthritis.
Silvagni E; Bortoluzzi A; Ciancio G; Govoni M
Pharmacol Res; 2019 Nov; 149():104473. PubMed ID: 31585178
[TBL] [Abstract][Full Text] [Related]
14. Malignancies developing in obese patients with psoriasis while on antitumour necrosis factor-α therapies: a case series.
Sadlier M; Lally A; Kirby B
Br J Dermatol; 2012 Oct; 167(4):937-8. PubMed ID: 22428935
[No Abstract] [Full Text] [Related]
15. Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient.
Lindsey SF; Weiss J; Lee ES; Romanelli P
J Drugs Dermatol; 2014 Jul; 13(7):869-71. PubMed ID: 25007373
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
[No Abstract] [Full Text] [Related]
17. Psoriatic arthritis for the dermatologist.
Tintle SJ; Gottlieb AB
Dermatol Clin; 2015 Jan; 33(1):127-48. PubMed ID: 25412788
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies for psoriatic arthritis: an update for the dermatologist.
Elman SA; Weinblatt M; Merola JF
Semin Cutan Med Surg; 2018 Sep; 37(3):173-181. PubMed ID: 30215635
[TBL] [Abstract][Full Text] [Related]
19. Apremilast for the treatment of psoriatic arthritis.
Souto A; Gómez-Reino JJ
Expert Rev Clin Immunol; 2015; 11(12):1281-90. PubMed ID: 26503917
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
